Related Experiment Video
Updated: Apr 18, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Deciphering the GPER/GPR30-agonist and antagonists interactions using molecular modeling studies, molecular dynamics,
D Méndez-Luna1, M Martínez-Archundia, Rachid C Maroun
1a Laboratorio de modelado Molecular y Diseño de Fármacos (Laboratory of Molecular Modeling and Drug Design), Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina , Instituto Politécnico Nacional , Plan de San Luis y Díaz Mirón, 11340 México, D.F. , Mexico.
Molecular modeling reveals the G-protein coupled estrogen receptor 1 (GPER1) structure and its interactions with various ligands, explaining its flexibility in binding diverse molecules for breast cancer research.
Area of Science:
- Molecular biology
- Structural biology
- Computational chemistry
Background:
- The G-protein coupled estrogen receptor 1 (GPER1/GPR30) is a key regulator in breast cancer growth and proliferation.
- The absence of a GPER1 crystal structure necessitates computational approaches to understand its function.
Purpose of the Study:
- To construct a 3D model of GPER1 using molecular modeling.
- To investigate GPER1's molecular recognition properties with known agonists and antagonists via docking studies.
- To elucidate the structural basis for GPER1's ligand-binding diversity.
Main Methods:
- Molecular modeling to build the initial GPER1 structure.
- Molecular dynamics (MD) simulations up to 120 ns for structural refinement.
- Molecular docking studies with various GPER1 ligands (agonists and antagonists).
Main Results:
- Identified the estradiol (E2) binding site and other ligand-accepting cavities within GPER1.
- Revealed key interactions, including π-π, hydrophobic, and hydrogen bonds, governing ligand binding.
- Observed conserved binding motifs for G1 and G15 across MD simulations.
- Identified potential protein activation residues (C107 and E275) based on ligand interactions.
Conclusions:
- GPER1 exhibits significant structural flexibility, enabling it to bind a wide array of ligands.
- Ligand binding poses can vary depending on GPER1's conformational states.
- These findings provide insights into GPER1's role in breast cancer and potential therapeutic strategies.
More Related Videos
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
09:21BRET-based G Protein Biosensors for Measuring G Protein-Coupled Receptor Activity in Live Cells
Published on: November 7, 2025
Related Concept Videos
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Drug-Receptor Interactions
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
The Two-State Receptor Model
The binding affinity of a drug determines its interaction with...
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Drug-Receptor Interaction: Antagonist
Antagonists can be classified as competitive or noncompetitive based on their...
Quantitative Aspects of Drug-Receptor Interaction